Related references
Note: Only part of the references are listed.Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity
Frederico Pittella et al.
BIOMATERIALS (2011)
Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration
Kareen Riviere et al.
JOURNAL OF DRUG TARGETING (2011)
Linear polyethyleneimine-based charge-reversal nanoparticles for nuclear-targeted drug delivery
Zhuxian Zhou et al.
JOURNAL OF MATERIALS CHEMISTRY (2011)
Targeting of the B-lineage leukemia stem cells and their progeny with norcantharidin encapsulated liposomes modified with a novel CD19 monoclonal antibody 2E8 in vitro
Jingying Zhang et al.
JOURNAL OF DRUG TARGETING (2010)
Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery
Youqing Shen et al.
NANOMEDICINE (2010)
Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery
Qin Wang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Charge-Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery
Zhuxian Zhou et al.
ADVANCED FUNCTIONAL MATERIALS (2009)
Poly(lactide-co-glycolide) nanoparticles as carriers for norcantharidin
Qingbing Zeng et al.
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS (2009)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Charge-conversion ternary polyplex with endosome disruption moiety: A technique for efficient and safe gene delivery
Yan Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Norcantharidin Analogues: Synthesis, Anticancer Activity and Protein Phosphatase 1 and 2A Inhibition
Timothy A. Hill et al.
CHEMMEDCHEM (2008)
Disodium norcantharidate-loaded poly(ε-caprolactone) microspheres II.: Modification of morphology and release behavior
Shaobing Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Anticancer activity and mechanisms of norcantharidin-Nd3II on hepatoma
Huayu Yang et al.
ANTI-CANCER DRUGS (2007)
Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells
Hui-Fen Liao et al.
FOOD AND CHEMICAL TOXICOLOGY (2007)
Estrogen receptor α mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death
Meihua Sui et al.
CANCER RESEARCH (2007)
A protein nanocarrier from charge-conversion polymer in response to endosomal pH
Yan Lee et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Targeted charge-reversal nanoparticles for nuclear drug delivery
Peisheng Xu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Novel polymeric microspheres containing norcantharidin for chemoembolization
Xiaohua Liu et al.
JOURNAL OF CONTROLLED RELEASE (2006)
A less irritant norcantharidin lipid microspheres: Formulation and drug distribution
Wang Lixin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Norcantharidin inhibits DNA replication and induces apoptosis with the cleavage of initiation protein Cdc6 in HL-60 cells (vol 17, pg 307, 2006)
Jin-Long Li et al.
ANTI-CANCER DRUGS (2006)
An investigation on liver-targeting microemulsions of norcantharidin
L Zhang et al.
DRUG DELIVERY (2005)
Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinorna cells
YJ Chen et al.
ANTI-CANCER DRUGS (2005)
Cationic charge-dependent hepatic delivery of amidated serum albumin
SF Ma et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio
SH Kok et al.
CANCER LETTERS (2005)
Modified norcantharidins: synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity
ME Hart et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Monoclonal antibody radiopharmaceuticals: Cationization, pegylation, radiometal chelation, pharmacokinetics, and tumor imaging
HJ Lee et al.
BIOCONJUGATE CHEMISTRY (2003)
Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines
A McCluskey et al.
BIOORGANIC CHEMISTRY (2003)
Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes
SH Kok et al.
ORAL ONCOLOGY (2003)
Folate-mediated delivery of macromolecular anticancer therapeutic agents
YJ Lu et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells
YN Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand
F Peng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Serine-threonine protein phosphatase inhibitors: Development of potential therapeutic strategies
A McCluskey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function
RK Jain
JOURNAL OF CONTROLLED RELEASE (2001)
Norcantharidin-induced post-G2/M apoptosis is dependent on wild-type p53 gene
CY Hong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
